2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999

• December 31, 2007
  FOREST AND CYPRESS ANNOUNCE SUBMISSION OF NEW DRUG APPLICATION FOR MILNACIPRAN FOR THE TREATMENT OF FIBROMYALGIA SYNDROME
• November 27, 2007
  Cypress Bioscience, Inc. TO PRESENT AT CIBC WORLD MARKETS 3RD ANNUAL MID & SMALL CAP 'BEST IDEAS' CONFERENCE
• November 26, 2007
  Cypress Bioscience, Inc. TO PRESENT AT LAZARD CAPITAL MARKETS FOURTH ANNUAL HEALTHCARE CONFERENCE
• November 12, 2007
  Cypress Bioscience, Inc. TO PRESENT AT CITI'S BIOTECH DAY
• November 9, 2007
  Cypress Bioscience, Inc. ANNOUNCES THIRD QUARTER 2007 RESULTS
• November 8, 2007
  MILNACIPRAN DEMONSTRATED SIGNIFICANT IMPROVEMENT IN PAIN AND THE CORE SYMPTOMS OF FIBROMYALGIA SYNDROME, DATA SHOW
• November 5, 2007
  Cypress Bioscience, Inc. TO PRESENT AT CIBC WORLD MARKETS 18TH ANNUAL HEALTHCARE CONFERENCE
• November 2, 2007
  FOREST LABORATORIES AND CYPRESS BIOSCIENCE TO HOST WEBCAST TO DISCUSS CLINICAL DATA PRESENTATIONS FOR MILNACIPRAN
• September 24, 2007
  Cypress Bioscience, Inc. TO PRESENT AT UBS GLOBAL LIFE SCIENCES CONFERENCE
• August 9, 2007
  Cypress Bioscience, Inc. ANNOUNCES SECOND QUARTER 2007 RESULTS
• June 26, 2007
  Cypress Bioscience, Inc. TO PRESENT AT JEFFERIES HEALTHCARE CONFERENCE
• June 13, 2007
  Cypress Bioscience, Inc. TO PRESENT AT NEEDHAM BIOTECHNOLOGY AND MEDICAL TECHNOLOGY CONFERENCE
• May 31, 2007
  Cypress Bioscience, Inc. ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK
• May 22, 2007
  CYPRESS BIOSCIENCE, INC. TO HOLD CONFERENCE CALL AND TO PRESENT AT CITIGROUP GLOBAL HEALTHCARE CONFERENCE
• May 22, 2007
  FOREST LABORATORIES, INC. AND CYPRESS BIOSCIENCE, INC. ANNOUNCE POSITIVE RESULTS OF PHASE III STUDY FOR MILNACIPRAN AS A TREATMENT FOR FIBROMYALGIA SYNDROME
• May 10, 2007
  Cypress Bioscience, Inc. ANNOUNCES FIRST QUARTER 2007 RESULTS
• April 11, 2007
  Cypress Bioscience, Inc. TO PRESENT AT CIBC WORLD MARKETS ANNUAL BIOTECHNOLOGY AND SPECIALTY PHARMACEUTICALS CONFERENCE
• March 14, 2007
  Cypress Bioscience, Inc. ANNOUNCES FOURTH QUARTER AND FISCAL YEAR END 2006 RESULTS
• March 5, 2007
  Cypress Bioscience, Inc. TO PRESENT AT OPPENHEIMER'S "POSITIONING INVESTORS FOR THE NEXT WAVE IN PAIN MANAGEMENT" CONFERENCE